Takeda acquires rights to new “Trojan horse” celiac antidote in US$420m deal

Takeda acquires rights to new “Trojan horse” celiac antidote in US$420m deal

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

08 Nov 2019 --- Allergy symptoms can range anywhere from annoying to painful to deadly. Therefore, industry is called upon to seek out the best methods to prevent allergies and... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

05 Nov 2019 --- Research from the National Institutes of Health (NIH), a US medical research agency, has revealed that sesame allergy is becoming increasingly common among... Read More

FormattedPicture

PACKAGING & TECHNOLOGY NEWS

23 Oct 2019 --- Responding to the steady increase in demand for non-allergen ingredients, EHL Ingredients has overhauled production processes to completely segregate lines for... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

27 Sep 2019 --- Nestlé Health Science has invested in Before Brands, specialists in early childhood food allergy prevention, to forward initiatives to prevent rising allergy... Read More

FormattedPicture

FOOD RESEARCH

22 Aug 2019 --- Scientists from Australia’s national science agency, Commonwealth Scientific and Industrial Research Organisation (CSIRO), can now detect gluten in any food... Read More

trans